Kenanova, V., Olafsen, T., Williams, L.E. Ruel, N.H., Longmate, J., Yazaki, P.J., Shively, J.E., Colcher, D., Raubitschek, A.A., and Wu, A.M. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy. Cancer Res. 2007 Jan 15;67(2):718-26.

Olafsen, T., Kenanova, V.E., Wu, A.M. Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nat Protoc. 2006;1(4):2048-60.

Ferl, G.Z., Kenanova, V., Wu, A.M., DiStefano, J.J. 3rd A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments. Mol Cancer Ther. 2006 Jun;5(6):1550-8.

Kenanova, V., Wu, A.M. Tailoring antibodies for radionuclide delivery. Expert Opin Drug Deliv. 2006 Jan;3(1):53-70.

Olafsen, T., Kenanova, V., Sundaresan, G., Anderson, A.L., Crow, D., Yazaki, P.J., Li, L., Press, M.F., Gambhir, S.S., Williams, L.E., Wong, J.Y.C., Raubitschek, A.A., Shively, J.E. and Wu, A.M. Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging. Cancer Res. 2005 Jul 1;65(13):5907-16.

Kenanova, V., Olafsen, T., Crow, D., Sundaresan, G., Subbarayan, M., Carter, N., Ikle, D., Yazaki, P.J., Chatziioannou, A., Gambhir, S.S., Williams, L.E., Shively, J.E., Colcher, D., Raubitschek, A.A. and Wu, A.M. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res. 2005 Jan 15;65(2):622-31.